Request Sample

Global Automated Antimicrobial Susceptibility Testing Market

Sept. 23, 2019

Global Automated Antimicrobial Susceptibility Testing Market, By Product Type (Automated Laboratory Instruments and Consumables), By Detection Method (Turbidimetric and Colorimetric), By End User (Diagnostic Laboratories and Hospitals, Pharmaceutical and, Biotechnology Companies, and Research and Academic Institutes), By Application (Antibacterial (Tuberculosis and Sepsis) and Antifungal (Anti-parasitic and Anti-viral) By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR532      
Pages :215 Pages
Format :   PPT Format   PDF Format

The global automated antimicrobial susceptibility testing market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and it is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). The objective of automated antimicrobial susceptibility testing is to diagnose possible drug resistance in ordinary pathogens and ensure the responsiveness of the drugs of choice for a specific infection. The most extensively used testing technique includes micro broth dilution, which is also known as rapid automated instrument methods that use economically marketed materials and equipment.. The execution of antimicrobial susceptibility testing by the clinical microbiology laboratory is crucial to authenticate susceptibility to selected empirical antimicrobial agents or to diagnose resistance in individual bacterial isolates. Increasing government ingenuity concerning the development of quality hospital infrastructure globally contributes to the growth of the automated antimicrobial susceptibility testing market.         

Table 1. Global Automated Antimicrobial Susceptibility Testing Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Product Type)

Automated Laboratory Instruments and Consumables

Market Segmentation (By Detection Method)

Turbidimetric and Colorimetric

Market Segmentation (By End User)

Diagnostic Laboratories and Hospitals, Pharmaceutical and, Biotechnology Companies, and Research and Academic Institutes

Market Segmentation (By Application)

Antibacterial (Tuberculosis and Sepsis) and Antifungal (Anti-parasitic and Anti-viral)

Regions Covered

North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa

Key Players Coverage

 Alifax SpA,  Accelerate Diagnostics, Inc.,Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Creative Diagnostics, Bioanalyse Tibbi Malz. San. ve Tic. Ltd. Sti., HiMedia Laboratories, Liofilchem S.r.l.,  Merlin Diagnostica GmbH, Merck KGaA,Synbiosis, Thermo Fisher Scientific, Inc., and Zhuhai Dl Biotech Co., Ltd.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Lately, the time has evidenced a significant movement towards personalized medicines and the development of new websites, which is surging the demand for automated antimicrobial susceptibility testing products and surging susceptibility to infectious disorders, which are estimated to widen the demand for automated antimicrobial susceptibility tests throughout the foresee future.

.  For instance, in December 2017, The U.S. Food and Drug Administration (FDA) released a new website focused on enhancing access to information that can assist healthcare professionals in deciding which drugs are most likely to work to treat bacterial or fungal infections.

. The website has been made under the efforts of 21st-century cures act, which has made it mandatory with the motive to combat increasing antimicrobial resistance by offering a central, convenient, accessible, and up-to-date repository for antimicrobial susceptibility interpretive criteria, also known as antimicrobial "breakpoints".

Moreover, due to increasing favorable regulations by the U.S. FDA acts as one of the major drivers for the automated antimicrobial susceptibility testing market. For instance, in April 2020, the U.S. Food and Drug Administration (FDA) gave approval to the micro broth dilution susceptibility plates due to which, antimicrobials Cefiderocol and imipenem/ relebactam are made available, enlarging testing options for microbiology laboratories, and furnishing the quantitative susceptibility outcomes clinicians requires to make treatment decisions for serious Gram-negative infections. This plan focuses on enhancing the capability of health care professionals to diagnose whether bacteria or fungal pathogens have generated resistance to antimicrobial drugs, containing novel drugs.  It will assist in quickly identifying the appropriate treatment for patients, lowering the use of broad-spectrum antibiotics, and conserve the potential of antimicrobial drugs and decrease the transmission of antimicrobial-resistant pathogens that can put people’s lives at danger.

However, various equipment recalls in the antimicrobial susceptibility market acts as critical challenges to the manufacturers and hence hinders the growth of automated antimicrobial susceptibility testing market, globally. For instance, in March 2019, an automated AST kit, Biomerieux Vitek 2, which is a System, test, automated, antimicrobial susceptibility, short incubation, has been recalled due to Unexpected ESBL (Extended Spectrum Beta Lactamase) phenotype had been proposed for some Escherichia coli strains in conjunction with the VITEK 2 AST-N254, AST-N330, AST-N371 test kits.

Figure 1. PORTER’S Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America, Europe, and the Asia Pacific are estimated to show major share in antimicrobial susceptibility market in the forecast period, as governments of these regions are majorly focusing on increasing the awareness about the treatment of infections occur due to pathogens and are eternally undertaking steps to promote automated antimicrobial susceptibility testing by new developments. For instance, in August 2019, in California, a new benchtop automated reading and incubation system has been launched for antimicrobial susceptibility testing (AST) which allows microbiology laboratories with the correct MIC results that clinicians require to confidently choose an effective antibiotic for critically-ill patients while protecting future patient care through more successful antimicrobial stewardship. Moreover, in 2018, the U.K. government released a five-year national action plan describing the contribution of the U.K. in managing the rising global issues of antimicrobial resistance.

In March 2018, the prime minister of India released the ‘TB Free India’ campaign to end tuberculosis (TB) by 2025 in India. These initiatives assist in instructing decision-makers, regulatory agencies, and other end-users regarding the prevention of infections, and hence, contributing towards the growth of the AST market in these regions.

Figure 2. Regional Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in the global automated antimicrobial susceptibility testing market include  Alifax SpA,  Accelerate Diagnostics, Inc.,Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Creative Diagnostics, Bioanalyse Tibbi Malz. San. ve Tic. Ltd. Sti., HiMedia Laboratories, Liofilchem S.r.l.,  Merlin Diagnostica GmbH, Merck KGaA,Synbiosis, Thermo Fisher Scientific, Inc., and Zhuhai Dl Biotech Co., Ltd.

Various productive strategies have been adopted by the key market players to blossom their share and position in the market in the view to increase their revenue these approaches mainly includeshuge investment on R&D, product innovations, increasing investment in online sales channels and receiving approvals from government. For instance, in February 2017, Accelerate Diagnostics, Inc. (Accelerate) declared that the U.S. Food and Drug Administration had given approval to the de novo request to market the Accelerate Pheno system and Accelerate PhenoTest BC kit for recognition and antibiotic susceptibility testing of pathogens right from positive blood culture samples. Further, in September 2016, BD (Becton, Dickinson and Company) a leading global medical technology firm, declared the release of its next-generation diagnostic device for the speedy identification of bacteria and detection of antimicrobial resistance, which is been proved to be an effective automated antimicrobial susceptibility testing device, globally.  

Figure 3. Market Share of Key Players, 2019

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Product Type

  • Automated Laboratory Instruments
  • Consumables

By Detection Method

  • Turbidimetric
  • Colorimetric

 By Application

  • Antibacterial
    • Tuberculosis
    • Sepsis
  • Antifungal
    • Anti-parasitic
    • Anti-viral

By End User

  • Diagnostic Laboratories and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides an in-depth analysis of the global automated antimicrobial susceptibility testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global automated antimicrobial susceptibility testing market?
  • What key factors are expected to increase the demand for automated antimicrobial susceptibility testing market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global automated antimicrobial susceptibility testing market?
  • What is the total market value (US$ Mn) generated in global automated antimicrobial susceptibility testing market by product type in 2019 and what are the forecasts by 2025?
  • Which application is expected to dominate the automated antimicrobial susceptibility testing market in the coming years?
  • Which detection method is expected to foster the automated antimicrobial susceptibility testing market growth?
  • Which end user contribute the highest CAGR (%) in the automated antimicrobial susceptibility testing market?
  • What was the total revenue generated by the global automated antimicrobial susceptibility testing market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global automated antimicrobial susceptibility testing market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the automated antimicrobial susceptibility testing market?
  • What are the major outcomes derived from Porter’s five forces?
  • What new products are going to be approved or launched in the coming years, which may have a huge impact on the market?
  • What insights are derived through the analysis of key players on the following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.